194 related articles for article (PubMed ID: 18000383)
1. Genetic and epigenetic alterations in myelodysplastic syndrome.
Mihara K; Takihara Y; Kimura A
Cytogenet Genome Res; 2007; 118(2-4):297-303. PubMed ID: 18000383
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic aspects of adult primary myelodysplastic syndromes: clinical implications.
Panani AD; Roussos C
Cancer Lett; 2006 Apr; 235(2):177-90. PubMed ID: 15935553
[TBL] [Abstract][Full Text] [Related]
4. Myelodysplastic syndromes: molecular pathogenesis and genomic changes.
Nolte F; Hofmann WK
Ann Hematol; 2008 Oct; 87(10):777-95. PubMed ID: 18516602
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review.
Bernasconi P
Br J Haematol; 2008 Sep; 142(5):695-708. PubMed ID: 18540941
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis?
Sieglová Z; Zilovcová S; Cermák J; Ríhová H; Brezinová D; Dvoráková R; Marková M; Maaloufová J; Sajdová J; Brezinová J; Zemanová Z; Michalová K
Leuk Res; 2004 Oct; 28(10):1013-21. PubMed ID: 15289012
[TBL] [Abstract][Full Text] [Related]
7. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature.
Swolin B; Rödjer S; Westin J
Ann Hematol; 2008 Jun; 87(6):467-74. PubMed ID: 18351338
[TBL] [Abstract][Full Text] [Related]
8. Myelodysplastic syndromes.
Cilloni D; Messa F; Carturan S; Arruga F; Defilippi I; Messa E; Gottardi E; Saglio G
Ann N Y Acad Sci; 2004 Dec; 1028():400-8. PubMed ID: 15650265
[TBL] [Abstract][Full Text] [Related]
9. Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromes.
Cilloni D; Messa E; Messa F; Carturan S; Defilippi I; Arruga F; Rosso V; Catalano R; Bracco E; Nicoli P; Saglio G
Ann N Y Acad Sci; 2006 Nov; 1089():411-23. PubMed ID: 17261784
[TBL] [Abstract][Full Text] [Related]
10. Molecular and genetic features of myelodysplastic syndromes.
Greenberg PL
Int J Lab Hematol; 2012 Jun; 34(3):215-22. PubMed ID: 22212119
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
Harada Y; Harada H
J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
[TBL] [Abstract][Full Text] [Related]
12. A polycomb repression signature in metastatic prostate cancer predicts cancer outcome.
Yu J; Yu J; Rhodes DR; Tomlins SA; Cao X; Chen G; Mehra R; Wang X; Ghosh D; Shah RB; Varambally S; Pienta KJ; Chinnaiyan AM
Cancer Res; 2007 Nov; 67(22):10657-63. PubMed ID: 18006806
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring.
Xu F; Li X; Wu L; Zhang Q; Yang R; Yang Y; Zhang Z; He Q; Chang C
Ann Hematol; 2011 Jun; 90(6):643-53. PubMed ID: 21125401
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplastic syndrome associated with monosomy 7 in childhood: a retrospective study.
Aktas D; Tuncbilek E
Cancer Genet Cytogenet; 2006 Nov; 171(1):72-5. PubMed ID: 17074595
[TBL] [Abstract][Full Text] [Related]
15. FLT3 internal tandem duplication during myelodysplastic syndrome follow-up: a marker of transformation to acute myeloid leukemia.
Pinheiro RF; de Sá Moreira E; Silva MR; Alberto FL; Chauffaille Mde L
Cancer Genet Cytogenet; 2008 Jun; 183(2):89-93. PubMed ID: 18503825
[TBL] [Abstract][Full Text] [Related]
16. Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology.
Disperati P; Ichim CV; Tkachuk D; Chun K; Schuh AC; Wells RA
Leuk Res; 2006 Feb; 30(2):233-9. PubMed ID: 16046234
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow mesenchymal stem cells in myelodysplastic syndromes: cytogenetic characterization.
Song LX; Guo J; He Q; Yang LP; Gu SC; Zhang X; Wu LY; Li X; Chang CK
Acta Haematol; 2012; 128(3):170-7. PubMed ID: 22890308
[TBL] [Abstract][Full Text] [Related]
18. Molecular bases of myelodysplastic syndromes: lessons from animal models.
Komeno Y; Kitaura J; Kitamura T
J Cell Physiol; 2009 Jun; 219(3):529-34. PubMed ID: 19259975
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of malignant renal stem cells is associated with epigenetic changes in normal renal progenitor genes.
Metsuyanim S; Pode-Shakked N; Schmidt-Ott KM; Keshet G; Rechavi G; Blumental D; Dekel B
Stem Cells; 2008 Jul; 26(7):1808-17. PubMed ID: 18467665
[TBL] [Abstract][Full Text] [Related]
20. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.
Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C
Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
